Does Dr. YASAMAN AHMADZADEH have financial conflicts of interest?

Dr. YASAMAN AHMADZADEH (MD) has received a total of $968 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $968 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. YASAMAN AHMADZADEH?

According to CMS Open Payments data, Dr. YASAMAN AHMADZADEH received funding from JANSSEN PHARMACEUTICALS ($272), ABBVIE ($125), and ALCRESTA THERAPEUTICS ($125).

Does Dr. YASAMAN AHMADZADEH receive research grants or speaking fees?

Dr. YASAMAN AHMADZADEH has received $968 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. YASAMAN AHMADZADEH

MDReal-Time Hydrated

Specialty: Internal Medicine

Practice Location: PROVIDENCE, RI 02908

NPI Number: 1164095881

LIFETIME INDUSTRY VALUE

$968

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. AHMADZADEH is a verified Internal Medicine practitioner based in PROVIDENCE, RI.

Between 2021 and 2024, Dr. AHMADZADEH had an overall industry promotional and research financial footprint of $968 as recorded in the federal CMS Open Payments database.

$968 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AHMADZADEH's primary funding source is JANSSEN PHARMACEUTICALS, which accounts for $272 (representing 28.1% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

JANSSEN PHARMACEUTICALS

Rank 1

$272

28.1%

ABBVIE

Rank 2

$125

13%

ALCRESTA THERAPEUTICS

Rank 3

$125

12.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.